1. Alberti, KGMM, Eckel, RH, Grundy, SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120: 1640–1645.
Google Scholar | Crossref | Medline2. World Health Organization . Obesity and overweight 2020, https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
Google Scholar3. National Health Service Digital . Statistics on obesity, physical activity and diet, England, 2020, 2020, https://digital.nhs.uk/data-and-information/publications/statistical/statistics-on-obesity-physical-activity-and-diet/england-2020
Google Scholar4. Baker, C . Obesity statistics – research briefing, 2021, https://commonslibrary.parliament.uk/research-briefings/sn03336/
Google Scholar5. Penson, DF, Munro, HM, Signorello, LB, et al. Obesity, physical activity and lower urinary tract symptoms: results from the southern community cohort study. J Urol 2011; 186: 2316–2322.
Google Scholar | Crossref | Medline6. Mondul, AM, Giovannucci, E, Platz, EA. A prospective study of obesity, and the incidence and progression of lower urinary tract symptoms. J Urol 2014; 191: 715–721.
Google Scholar | Crossref | Medline7. Parsons, JK, Bergstrom, J, Barrett-Connor, E. Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men. BJU Int 2008; 101: 313–318.
Google Scholar | Crossref | Medline8. Abdelmoteleb, H, Jefferies, ER, Drake, MJ. Assessment and management of male lower urinary tract symptoms (LUTS). Int J Surg 2015; 25: 164–171.
Google Scholar | Crossref | Medline9. Stewart, W, Van Rooyen, JB, Cundiff, GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327–336.
Google Scholar | Crossref | Medline10. Demir, O, Akgul, K, Akar, Z, et al. Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome. Aging Male 2009; 12: 29–34.
Google Scholar | Crossref | Medline11. Lee, SH, Lee, SK, Choo, MS, et al. Relationship between metabolic syndrome and lower urinary tract symptoms: Hallym Aging Study. Biomed Res Int 2015; 2015: 130917.
Google Scholar | Medline12. Telli, O, Demirbas, A, Kabar, M, et al. Does metabolic syndrome or its components correlate with lower urinary tract symptoms in benign prostatic hyperplasia patients? Nephrourol Mon 2015; 7: e27253.
Google Scholar | Crossref | Medline13. Gao, Y, Wang, M, Zhang, H, et al. Are metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population survey. Urology 2012; 79: 194–201.
Google Scholar | Crossref | Medline14. Higgins, J, Thomas, J, Chandler, J, et al. Cochrane handbook for systematic reviews of interventions, version 6.1. Cochrane, 2020, https://training.cochrane.org/handbook/current
Google Scholar | Crossref15. Covidence systematic review software, Covidence 2020. Cochrane Community, www.covidence.org
Google Scholar16. Wells, G, Shea, B, O’Connell, D, et al. The Newcastle–Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analysis, 2000, https://www.researchgate.net/publication/261773681_The_Newcastle-Ottawa_Scale_NOS_for_Assessing_the_Quality_of_Non-Randomized_Studies_in_Meta-Analysis
Google Scholar17. Hayden, JA, van der Windt, DA, Cartwright, JL, et al. Assessing bias in studies of prognostic factors. Ann Intern Med 2013; 158: 280–286.
Google Scholar | Crossref | Medline18. Park, YW, Min, SK, Lee, JH. Relationship between lower urinary tract symptoms/benign prostatic hyperplasia and metabolic syndrome in Korean men. World J Mens Health 2012; 30: 183–188.
Google Scholar | Crossref | Medline19. Gacci, M, Sebastianelli, A, Salvi, M, et al. The impact of central obesity on storage LUTS and urinary incontinence after prostatic surgery. Curr Urol Rep 2016; 17: 61.
Google Scholar | Crossref | Medline20. Russo, GI, Vanella, L, Castelli, T, et al. Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients. World J Urol 2016; 34: 1183–1192.
Google Scholar | Crossref | Medline21. Moher, D, Liberati, A, Tetzlaff, J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
Google Scholar | Crossref | Medline22. Akin, Y, Gulmez, H, Savas, M, et al. Relationship between neck circumference and overactive bladder in women with metabolic syndrome: a preliminary study. Wien Klin Wochenschr 2016; 128(Suppl. 8): 581–586.
Google Scholar | Crossref | Medline23. Aktas, BK, Gokkaya, CS, Bulut, S, et al. Impact of metabolic syndrome on erectile dysfunction and lower urinary tract symptoms in benign prostatic hyperplasia patients. Aging Male 2011; 14: 48–52.
Google Scholar | Crossref | Medline24. Barbosa, JABA, Muracca, E, Nakano, E, et al. Risk factors for male lower urinary tract symptoms: the role of metabolic syndrome and androgenetic alopecia in a Latin American population. Urology 2013; 82: 182–188.
Google Scholar | Crossref | Medline25. Baykam, MM, Aktas, BK, Bulut, S, et al. Association between prostatic resistive index and cardiovascular risk factors in patients with benign prostatic hyperplasia. Kaohsiung J Med Sci 2015; 31: 194–198.
Google Scholar | Crossref | Medline26. Bray, R, Cacciatore, S, Jiménez, B, et al. Urinary metabolic phenotyping of women with lower urinary tract symptoms. J Proteome Res 2017; 16: 4208–4216.
Google Scholar | Crossref | Medline27. Byun, HK, Sung, YH, Kim, W, et al. Relationships between prostate-specific antigen, prostate volume, and components of metabolic syndrome in healthy Korean men. Korean J Urol 2012; 53: 774–778.
Google Scholar | Crossref | Medline28. Choi, WS, Heo, NJ, Paick, J, et al. Prostate-specific antigen lowering effect of metabolic syndrome is influenced by prostate volume. Int J Urol 2016; 23: 299–304.
Google Scholar | Crossref | Medline29. Chung, MS, Chuang, YC, Lee, JJ, et al. Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes. Int Urol Nephrol 2014; 46: 1269–1275.
Google Scholar | Crossref | Medline30. Coban, S, Cander, S, Altuner, MS, et al. Does metabolic syndrome increase erectile dysfunction and lower urinary tract symptoms. Urol J 2014; 11: 1820–1824.
Google Scholar | Medline31. Dagdeviren, H, Cengiz, H. Association between metabolic syndrome and serum nerve growth factor levels in women with overactive bladder. Gynecol Obstet Invest 2018; 83: 140–144.
Google Scholar | Crossref | Medline32. De Nunzio, C, Brassetti, A, Proietti, F, et al. Metabolic syndrome and smoking are associated with an increased risk of nocturia in male patients with benign prostatic enlargement. Prostate Cancer Prostatic Dis 2018; 21: 287–292.
Google Scholar | Crossref | Medline33. De Nunzio, C, Cindolo, L, Gacci, M, et al. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms. Urology 2014; 84: 1181–1187.
Google Scholar | Crossref | Medline34. De Nunzio, C, Lombardo, R, Gacci, M, et al. Metabolic syndrome does not increase the risk of ejaculatory dysfunction in patients with lower urinary tract symptoms and benign prostatic enlargement: an Italian Single Center Cohort Study. Urology 2017; 105: 85–90.
Google Scholar | Crossref | Medline35. De Nunzio, C, Tema, G, Lombardo, R, et al. Metabolic syndrome and smoking are associated with persistence of nocturia after transurethral resection of the prostate. Neurourol Urodyn 2019; 38: 1692–1699.
Google Scholar | Crossref | Medline36. Dogˇan, Y, Uruç, F, Aras, B, et al. The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia. Turk J Urol 2015; 41: 7–12.
Google Scholar | Crossref | Medline37. Eom, CS, Park, JH, Cho, BL, et al. Metabolic syndrome and accompanying hyperinsulinemia have favorable effects on lower urinary tract symptoms in a generally healthy screened population. J Urol 2011; 186: 175–179.
Google Scholar | Crossref | Medline38. Eren, H, Horsanali, MO. The independent association of non-alcoholic fatty liver disease with lower urinary tract symptoms/benign prostatic hyperplasia and erectile function scores. BJU Int 2019; 124: 329–335.
Google Scholar | Crossref | Medline39. Fu, Y, Zhou, Z, Yang, B, et al. The relationship between the clinical progression of benign prostatic hyperplasia and metabolic syndrome: a prospective study. Urol Int 2016; 97: 330–335.
Google Scholar | Crossref | Medline40. Gacci, M, Vignozzi, L, Sebastianelli, A, et al. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation. Prostate Cancer Prostatic Dis 2013; 16: 101–106.
Google Scholar | Crossref | Medline41. Gacci, M, Sebastianelli, A, Salvi, M, et al. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study. BMC Urol 2017; 17: 22.
Google Scholar | Crossref | Medline42. Haghsheno, MA, Mellström, D, Peeker, R, et al. Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement. Scand J Urol 2015; 49: 155–161.
Google Scholar | Crossref | Medline43. Jeong, JH, Kim, ET, Kim, DK. Association of metabolic syndrome and benign prostate enlargement in young Korean males. Korean J Urol 2011; 52: 757–762.
Google Scholar | Crossref | Medline44. Karoli, R, Bhat, S, Fatima, J, et al. A study of bladder dysfunction in women with type 2 diabetes mellitus. Indian J Endocrinol Metab 2014; 18: 552–557.
Google Scholar | Crossref | Medline45. Kim, JH, Doo, SW, Yun, JH, et al. Lower likelihood of having moderate-to-severe lower urinary tract symptoms in middle-aged healthy Korean men with metabolic syndrome. Urology 2014; 84: 665–669.
Google Scholar | Crossref | Medline46. Kupelian, V, McVary, KT, Kaplan, SA, et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey. J Urol 2013; 189: S107–S114.
Google Scholar | Crossref | Medline47. Kwon, T, Park, S, Park, S, et al. Metabolic syndrome is predictive of lower urinary tract symptom improvement after Holmium laser enucleation of the prostate for benign prostatic obstruction. Int Urol Nephrol 2017; 49: 1105–1110.
Google Scholar | Crossref | Medline48. Lai, HH, Helmuth, ME, Smith, AR, et al. Relationship between central obesity, general obesity, overactive bladder syndrome and urinary incontinence among male and female patients seeking care for their lower urinary tract symptoms. Urology 2019; 123: 34–43.
Google Scholar | Crossref | Medline49. Lee, RK, Chung, D, Chughtai, B, et al. Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms. BJU Int 2012; 110: 540–545.
Google Scholar | Crossref | Medline50. Lotti, F, Corona, G, Vignozzi, L, et al. Metabolic syndrome and prostate abnormalities in male subjects of infertile couples. Asian J Androl 2014; 16: 295–304.
Google Scholar | Crossref | Medline